Grifols SA Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/28/2026)
| Balance Sheet | Total Assets | 19,758,000,000.00 | ROE | 26.74 % |
| Balance Sheet | Total Equity | 7,603,000,000.00 | ROA | 2.04 % |
| Cashflow | Capital Expenditures | -423,000,000.00 | P/FCF | 7.17 |
| Cashflow | Free Cash Flow | 624,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,047,000,000.00 | P/CF | 4.27 |
| Income | Earnings per Share (diluted) | 0.59 | Div. Yield | – |
| Income | Net Income | 402,000,000.00 | P/E | 11.14 |
| Income | Shares Outstanding | 680,575,300.00 | P/B | 0.85 |
| Income | Total Revenue | 7,524,000,000.00 | P/S | 0.59 |
Ratios calculated on: 10/14/2026
Company Description
Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.grifols.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more